Finasteride Cost in California 2026

What Does Finasteride Actually Cost in California Right Now?

Generic finasteride 1 mg and 5 mg tablets are widely available across California, and cash prices in 2026 average about $12 per month at retail chains when patients use discount programs. The Merck brand (Propecia at 1 mg, Proscar at 5 mg) carries a list price near $85/month, but almost no cash-pay patient needs to pay that figure given the generic market.

Price variation across California zip codes is real. A 30-tablet supply of generic finasteride 1 mg can range from $9 at a warehouse club pharmacy to $22 at an independent community pharmacy without a discount card. The 5 mg tablet used for benign prostatic hyperplasia (BPH) is often cheaper per milligram than the 1 mg androgenetic alopecia (AGA) dose, and some patients prescribed 5 mg tablets split them into quarters under physician guidance to reduce cost further, though tablet-splitting should only be done after discussing formulation uniformity with a pharmacist.

Finasteride is a type II and type III 5-alpha reductase inhibitor. It blocks conversion of testosterone to dihydrotestosterone (DHT), the androgen primarily responsible for AGA progression and prostate enlargement. The FDA approved finasteride 1 mg for male AGA in 1997 and 5 mg for BPH in 1992. Full prescribing information is available on the FDA label database.

In Kaufman et al. (J Am Acad Dermatol 1998, N=1,553), finasteride 1 mg daily for 2 years halted progression of hair loss in 83% of men and produced visible regrowth in 66%, establishing the clinical benchmark still cited in most prescribing guidelines today. pubmed.ncbi.nlm.nih.gov/9777765

California has more than 6,700 licensed retail pharmacies, so competitive pricing is substantial. GoodRx, NeedyMeds, and the generic manufacturer discount cards each pull the cash price below $15/month at most major chains, including CVS, Walgreens, Rite Aid, Costco, and Walmart. NeedyMeds maintains a current California pharmacy price comparison tool.

Does Medi-Cal (California Medicaid) Cover Finasteride?

Medi-Cal covers finasteride, but the path depends on the diagnosis code on the prescription. BPH (ICD-10 N40.x) receives coverage with prior authorization (PA) for most Medi-Cal managed care plans. AGA coverage is more restricted because many plans classify it as cosmetic, yet finasteride for AGA remains on the Medi-Cal formulary and PA approval is granted when the prescriber documents medical necessity.

A 2022 analysis of Medicaid formulary data published through CMS showed that 38 state Medicaid programs covered finasteride for BPH, with California among those requiring PA rather than step therapy. CMS Medicaid Drug Rebate Program data can be searched at the official portal.

The PA process for Medi-Cal typically asks the prescriber to document: confirmed diagnosis (urodynamic or PSA evidence for BPH, or photographic/dermoscopy evidence for AGA), prior therapeutic trials where relevant, and absence of contraindications such as female sexual partners of childbearing age handling crushed tablets. Processing time is 3, 5 business days for standard PA and 24 to 72 hours for urgent PA. California's Medi-Cal pharmacy benefit documentation guidelines are maintained by DHCS.

Once approved, Medi-Cal beneficiaries pay $1, $3 copay per fill under the standard cost-sharing schedule. Patients enrolled in a Medi-Cal managed care plan should contact their plan's pharmacy benefit manager directly, since formulary tier placement may differ by plan.

Is Compounded Finasteride Legal in California?

Compounded finasteride is legal in California when prepared by a pharmacy operating under Section 503A of the federal Food, Drug and Cosmetic Act and holding a current California State Board of Pharmacy compounding license. These pharmacies compound on a patient-specific, prescription basis. They do not manufacture large commercial batches, which would instead require 503B outsourcing-facility registration with the FDA.

The California State Board of Pharmacy enforces compounding standards under Business and Professions Code Section 4126 and related regulations. A 503A pharmacy in California may prepare finasteride in non-commercially-available forms, such as topical solutions (commonly 0.1%, 0.25% finasteride in a hydroalcoholic base), custom capsule strengths, or combination formulations that pair finasteride with minoxidil. Board of Pharmacy compounding requirements are published at pharmacy.ca.gov.

Topical finasteride has attracted significant clinical interest because systemic DHT suppression may be lower than with oral dosing, potentially reducing the risk of sexual side effects. A 2021 randomized trial (Panchaprateep and Lueangarun, Dermatol Ther, N=40) found that 0.25% topical finasteride solution applied daily for 24 weeks reduced scalp DHT comparably to oral 1 mg while producing smaller reductions in serum DHT. pubmed.ncbi.nlm.nih.gov/33094892

Compounded finasteride from a California 503A pharmacy typically costs $35, $55/month, with an average near $45/month for a topical formulation. Oral compounded capsules at non-standard strengths run closer to $30, $40/month. These prices exceed the $12/month generic oral tablet, so the decision to use a compounded product should be driven by clinical rationale (e.g., intolerance to oral therapy, preference for topical delivery) rather than cost savings.

The FDA has not placed finasteride on its list of drugs that may not be compounded (the "Difficult to Compound" or "Demonstrably Copies" lists). FDA compounding guidance is updated at fda.gov/drugs/human-drug-compounding.

How Telehealth Prescribing Works for Finasteride in California

California permits synchronous and asynchronous telehealth encounters for finasteride prescribing. A licensed California physician, nurse practitioner, or physician assistant may prescribe finasteride after an appropriate evaluation conducted entirely via video or, for established patients, via secure messaging under the state's telehealth parity standards.

California Health and Safety Code Section 1374.13 and Business and Professions Code Section 2290.5 define the telehealth standard of care. The standard requires that the prescriber establish a valid patient-provider relationship and document clinical findings sufficient to support the prescription. For AGA this typically means a patient history, symptom onset timeline, and a review of any photos the patient submits, combined with a review of contraindications. California BPC 2290.5 is published at leginfo.legislature.ca.gov.

Telehealth platforms operating in California must route prescriptions through California-licensed pharmacies or partner with pharmacies holding non-resident pharmacy permits from the California State Board of Pharmacy. Many national telehealth hair-loss platforms (such as Keeps, Hims, and Roman) hold or partner with entities holding these permits, so California patients can receive finasteride by mail with no in-person visit required.

One practical advantage of telehealth for finasteride: prescription renewal requires only an asynchronous check-in on most platforms, lowering the total annual cost of care compared with repeated in-office dermatology visits, which may cost $150, $300 per consultation before insurance in California.

What Insurance Plans Cover Finasteride in California?

Coverage varies substantially by plan type, diagnosis, and formulary design. For BPH, most commercial plans in California, including Anthem Blue Cross, Blue Shield of California, Kaiser Permanente, and Health Net, place generic finasteride 5 mg on Tier 1 or Tier 2, meaning a copay of $5, $20 per 30-day fill. For AGA, the same plans may place finasteride 1 mg on a higher tier or exclude it as cosmetic, requiring an appeal with medical necessity documentation.

The Affordable Care Act (ACA) marketplace plans sold through Covered California must comply with the state's essential health benefit benchmark. BPH treatment qualifies as a covered essential health benefit; AGA treatment generally does not trigger that protection. Covered California formulary search is available at coveredca.com.

Patients whose commercial insurance excludes finasteride for AGA can appeal using documentation from guidelines such as the American Academy of Dermatology (AAD) guidance on AGA, which supports finasteride 1 mg as a first-line pharmacologic treatment for male AGA. The AAD has stated: "Finasteride 1 mg/day is an effective treatment for men with androgenetic alopecia and should be considered first-line pharmacologic therapy." AAD clinical guidelines on hair loss are hosted at aad.org.

Medicare Part D covers finasteride 5 mg for BPH under most plan formularies. Medicare does not cover finasteride 1 mg for AGA because Medicare Part D excludes drugs used for cosmetic purposes. California's State Health Insurance Assistance Program (SHIP) can help Medicare beneficiaries compare Part D plan formularies. SHIP resources are at aging.ca.gov.

What Is the Cheapest Way to Get Finasteride in California?

The lowest total monthly cost in 2026 for most California patients is generic finasteride 1 mg or 5 mg obtained with a GoodRx, RxSaver, or NeedyMeds coupon at a high-volume retail or warehouse pharmacy. Prices at Costco and Walmart pharmacies using these coupons average $9, $11 per 30-tablet supply, making finasteride one of the more accessible prescription medications on the market.

The HealthRX cost-minimization framework for California finasteride patients ranks strategies as follows:

1. Generic tablet plus discount card at warehouse or big-box pharmacy ($9, $12/month).
2. Medi-Cal or commercial insurance with Tier 1 copay ($1, $20/month depending on plan).
3. Patient assistance programs through the generic manufacturer or Merck's Propecia savings program for eligible patients ($0, $15/month for qualifying income levels).
4. Telehealth platform subscription that bundles the prescription and pharmacy fill ($20, $35/month all-in, but adds convenience and clinical oversight).
5. Compounded finasteride from a 503A pharmacy for patients who require a non-standard formulation ($35, $55/month).

No patient in California should pay the $85/month brand list price for finasteride given that generic versions contain the identical active pharmaceutical ingredient at FDA-mandated bioequivalence standards. The FDA defines bioequivalence for oral finasteride as 80 to 125% of the reference listed drug's AUC and Cmax in 90% confidence intervals. FDA bioequivalence standards are described at fda.gov/drugs/development-resources/bioequivalence-studies.

Manufacturer patient assistance: Merck offers a savings card for Propecia that may reduce the brand price to $30/month for commercially insured patients who do not qualify for Medi-Cal. Generic manufacturers including Cipla, Aurobindo, and Camber offer their own rebate programs. Checking the specific manufacturer's website or asking the dispensing pharmacist which manufacturer's lot is in stock allows patients to apply the correct card.

What Are the Clinical Benchmarks That Justify the Cost?

The cost-effectiveness of finasteride is well-established. Kaufman et al. (1998, N=1,553) demonstrated 83% of men experienced no further hair loss at 2 years on finasteride 1 mg, with a mean hair count increase of 107 hairs per cm² over placebo at the vertex. pubmed.ncbi.nlm.nih.gov/9777765

A longer-term open-label extension study (Price et al., J Am Acad Dermatol 2006, N=279) found sustained efficacy at 5 years of continuous therapy, with 90% of men maintaining or improving hair count compared with baseline. pubmed.ncbi.nlm.nih.gov/16488333

For BPH, the PLESS trial (Proscar Long-term Efficacy and Safety Study, N=3,040 to 4 years) showed finasteride 5 mg reduced the risk of acute urinary retention by 57% and the need for BPH-related surgery by 55% compared with placebo, supporting its cost-effectiveness for that indication. pubmed.ncbi.nlm.nih.gov/9474398

A 2014 cost-effectiveness analysis published in the Journal of Urology modeled finasteride versus watchful waiting for BPH and found finasteride cost-effective at a threshold of $50,000 per quality-adjusted life year (QALY) gained in moderate-to-severe cases, which is within the standard U.S. willingness-to-pay threshold. pubmed.ncbi.nlm.nih.gov/24239458

At $12/month ($144/year) for generic finasteride, the drug is exceptionally affordable by any standard cost-effectiveness metric.

Safety Profile and Monitoring in California Clinical Practice

Finasteride's adverse effect profile is well-characterized. Sexual side effects (decreased libido, erectile dysfunction, ejaculation disorder) occur in approximately 3.8% of men in clinical trials versus 2.1% on placebo, based on the finasteride 1 mg prescribing information. accessdata.fda.gov prescribing information for finasteride 1 mg.

Post-market safety data led the FDA to require a label update in 2012 adding persistent sexual side effects and reports of depression as potential risks even after drug discontinuation. FDA Drug Safety Communication 2012 is archived at fda.gov/drugs/drug-safety-and-availability.

California clinicians should note that the Prostate Cancer Prevention Trial (PCPT, N=18,882) found finasteride 5 mg reduced the overall prostate cancer detection rate by 24.8% but was associated with a higher rate of high-grade (Gleason 7, 10) tumors in the finasteride arm (6.4% vs. 5.1%, P<0.001). Subsequent analyses suggested this finding was partly due to detection bias from prostate volume reduction. pubmed.ncbi.nlm.nih.gov/12824459

Routine monitoring for finasteride does not require blood draws at every visit, but baseline PSA should be recorded before starting 5 mg therapy for BPH, since finasteride approximately halves PSA values within 6 months, and an elevated PSA on finasteride may indicate prostate pathology even if the absolute value appears normal. The American Urological Association guidelines recommend doubling the PSA value in men on finasteride to obtain the "finasteride-adjusted PSA" for screening purposes. AUA BPH guidelines are at auanet.org.

Finasteride is pregnancy category X and poses a teratogenic risk to male fetuses. California pharmacies are required to dispense finasteride with the FDA Medication Guide. Women of childbearing potential should not handle crushed or broken tablets. FDA Medication Guide for finasteride is at accessdata.fda.gov.

How to Get a Finasteride Prescription in California in 2026

California patients have three practical routes: a primary care physician, a dermatologist or urologist (specialty-dependent on indication), or a telehealth platform. Primary care physicians in California can prescribe both the 1 mg AGA and 5 mg BPH formulations without referral.

For AGA, telehealth platforms that operate in California include Keeps, Hims, Roman, and HealthRX. Most charge a monthly subscription of $20, $35 that bundles the prescription, provider visit, and pharmacy fill. Patients typically complete an intake questionnaire, submit photographs, and receive a prescription within 24 to 48 hours. Ongoing care is managed asynchronously through the platform's messaging system.

For BPH, a urologist visit is often preferred to rule out prostate cancer and confirm the diagnosis before starting finasteride, particularly in men over 50 with a PSA above 1.5 ng/mL. California has approximately 1,200 practicing urologists (per California Medical Board licensee data), with concentrations in Los Angeles, the Bay Area, San Diego, and Sacramento, making specialist access reasonable for most urban residents but limited in rural counties. California Medical Board licensee lookup is at mbc.ca.gov.

Once prescribed, patients can route the prescription to any California-licensed pharmacy or, for telehealth platforms, to a partner mail-order pharmacy. Prescription transfer to a discount pharmacy (such as Cost Plus Drugs, which lists finasteride 1 mg at $7.80/month as of early 2025) is permitted under California law and requires only a written or electronic prescription transfer request. Cost Plus Drugs pricing is at costplusdrugs.com.